Rolziracetam is primarily investigated for its potential cognitive-enhancing effects, particularly in the context of neurological disorders. It has been studied for its ability to improve memory, learning, and overall brain function, making it a candidate for treating conditions like Alzheimer's disease, dementia, and other forms of cognitive impairment. Additionally, it has been explored for its neuroprotective properties, which could help in mitigating brain damage caused by strokes or traumatic brain injuries. Research also suggests its potential in addressing attention deficit disorders and enhancing mental performance in healthy individuals, though further studies are needed to confirm these applications.